Nav: Home

Mattresses could emit higher levels of VOCs during sleep

July 10, 2019

Hundreds of household items, including furniture, paint and electronics, emit volatile organic compounds (VOCs), which at high levels can pose health risks. Now, researchers reporting in ACS' Environmental Science & Technology have measured the emission rates of the gaseous compounds released by several types of polyurethane mattresses under simulated sleeping conditions, finding levels of some VOCs that could be worrisome for children and infants. However, so far there is no evidence of adverse health effects.

Exposure to high levels of VOCs can cause eye, nose and throat irritation, headaches, and for some compounds, even cancer. During sleep, people likely inhale more VOCs because of poor bedroom ventilation and the close proximity of their nose and mouth to mattresses and bedding that emit the compounds. Yael Dubowski and colleagues wanted to measure the levels of several VOCs released by eight different infant, toddler and youth polyurethane mattresses and compare these to the risk levels for the compounds. Also, the researchers wanted to investigate how temperature, humidity and carbon dioxide concentration -- all of which are increased when people lie on a mattress for a few hours compared to the mattress alone -- could affect emissions.

The team placed pieces of polyurethane mattresses into continuous flow chambers, collected the exiting air and analyzed the levels of 18 different VOCs by gas chromatography-mass spectrometry. They found that the eight mattresses released quite similar amounts of VOCs, except for a flame retardant compound emitted only by an infant mattress. The mattresses released more VOCs when temperature was elevated to simulate body heat. The team estimated the doses of VOCs inhaled by adults, infants and children, finding that most were well below the cancer and non-cancer risk reference levels for these compounds. However, for infants and young children, inhalation of some compounds (for example, acetaldehyde, formaldehyde and benzene) could reach levels of concern. The researchers emphasize the need for further studies on possible health effects of chronic, low-level exposure to VOCs.
-end-
The authors acknowledge funding from the Environment and Health Fund (Israel).

The paper's abstract will be available on July 10 at 8 a.m. Eastern time here: http://pubs.acs.org/doi/abs/acs.est.9b01557

For more research news, journalists and public information officers are encouraged to apply for complimentary press registration for the ACS fall 2019 national meeting in San Diego.

The American Chemical Society, the world's largest scientific society, is a not-for-profit organization chartered by the U.S. Congress. ACS is a global leader in providing access to chemistry-related information and research through its multiple databases, peer-reviewed journals and scientific conferences. ACS does not conduct research, but publishes and publicizes peer-reviewed scientific studies. Its main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.

Follow us: Twitter | Facebook

American Chemical Society

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...